Ipamorelin is a selective pentapeptide growth hormone secretagogue that acts as a ghrelin receptor (GHS-R1a) agonist, investigated for its specificity toward GH release without significant co-stimulation of cortisol or prolactin pathways
BPC-157 vs TB-500 BPC-157 and TB-500 are chemically unrelated and mechanistically complementary, which is why they are so often paired in preclinical tissue-repair designs
Yes, GLP-1 medication shortages have largely resolved as of 2024, expanding patient access to multiple formulations and dosing options
Side effects may include nausea, vomiting, diarrhea, constipation, and stomach pain, most are mild and decrease over time as dosing is titrated
Under the Human Medicines Regulations 2012, the supply and advertising of unlicensed medicines for human use is restricted